Learn More
Invitrogen™ SUMO-3 Recombinant Rabbit Monoclonal Antibody (1H9L17)
Description
This antibody is predicted to react with chimpanzee and Rhesus monkey based on sequence homology. Intact IgG appears on a non-reducing gel as ~150 kDa band and upon reduction generating a ~25 kDa light chain band and a ~50 kDa heavy chain. Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Specifications
Specifications
| Antigen | SUMO-3 |
| Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | 1H9L17 |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide |
| Gene | SUMO3 |
| Gene Accession No. | P55854, Q5XIF4, Q9Z172 |
| Gene Alias | 2810014B19Rik; D10Ertd345e; small ubiquitin like modifier 3; small ubiquitin-like modifier 3; small ubiquitin-related modifier 3; SMT3 (supressor of mif two, 3) homolog 1; SMT3 homolog 1; SMT3 suppressor of mif two 3 homolog 1; SMT3 suppressor of mif two 3 homolog 3; SMT3 suppressor of mif two 3 homolog 3 (yeast); Smt3A; Smt3B; SMT3H1; SUMO-2; Sumo3; SUMO-3; Ubiquitin-like protein SMT3A; ubiquitin-like protein SMT3B |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.